DaVita (DVA) Tops Q3 EPS by 3c, Slight Beat on Revenues
Tweet
Share
E-mail
Get Alerts DVA Hot Sheet
Price: $180.06 -2.14%
EPS Growth %: +43.8%
Financial Fact:
Patient care costs: 2.7B
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: +43.8%
Financial Fact:
Patient care costs: 2.7B
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
DaVita (NYSE: DVA) reported Q3 EPS of $0.97, $0.03 better than the analyst estimate of $0.94. Revenue for the quarter came in at $3.92 billion versus the consensus estimate of $3.9 billion.
For earnings history and earnings-related data on DaVita (DVA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Casey's General Stores (CASY) Tops Q1 EPS by 69c
- GameStop beats second quarter estimates on collectibles
- Braze stock tumbles 10% on weak third quarter EPS guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
